3PC-011 Hplc method development and validation to determinate resorcinol for quality control in pharmaceutical formulations

BACKGROUND: The hidradenitis suppurativa (HS) is an inflammatory skin disease. Resorcinol is a phenol derivate, and in topical self-treatment decreases the size and pain of HS lesions. Topical 15% resorcinol is prepared as a pharmaceutical compound. In current literature, high performance liquid chr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Ramos, J Cordero, Bohórquez, V Merino, Real, M Vazquez, Castro, C Muñoz, Cernická, D, Orland, A Fernandez, Fernandez, M Camean
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 3: Production and compounding
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535285/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.63
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares